Regulatory
Published the 15 February 2021Invent Medic announces that the company has submitted an application to FDA for 510(k) market registration of the product Efemia bladder support in the United States. Invent Medic expects to be able to present marketing and sales plans for the product in the United...
Regulatory
Published the 11 February 2021The Board of Directors and the President will issue the following financial statements for the 2020 financial year. Unless otherwise specified, all amounts are reported in integers (SEK). Data in parentheses refer to the previous year. CEO Karin Bryder summarizes We...
Published the 25 January 2021Invent Medic announces that CEO Karin Bryder will present the company at the Swedish investor event Aktiedagen i Lund on January 27, 2021 at 9.15 CET. The event can be viewed live or on demand via Aktiespararna’s YouTube channel or via aktiespararna.se. Invent Medic’s...
Regulatory
Published the 14 December 2020Invent Medic announces that the company has signed a distribution agreement with Madrid-based En Suelo Firme, a company specialized in offering pelvic floor health products to Spanish-speaking women in Europe. En Suelo Firme has a strong social media presence, with...
Published the 11 December 2020Invent Medic today publishes a new edition of the company’s newsletter aimed at shareholders, investors, and other stakeholders. In this edition, CEO Karin Bryder comments that the company has been preparing for the submission for market registration of Efemia...
Regulatory
Published the 27 October 2020Solid sales in Sweden and Norway, while other markets are still affected by the corona pandemic FIRST NINE MONTHS (January–September 2020) The company’s sales amounted to 1,161 (248) KSEK. Other operating income amounted to 13 (0) KSEK. Operating costs amounted to...
